Page last updated: 2024-10-31

entinostat and Granulocytic Leukemia

entinostat has been researched along with Granulocytic Leukemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Conte, M1
Dell'Aversana, C1
Benedetti, R1
Petraglia, F1
Carissimo, A1
Petrizzi, VB1
D'Arco, AM1
Abbondanza, C1
Nebbioso, A1
Altucci, L1
Gaymes, TJ1
Shall, S1
MacPherson, LJ1
Twine, NA1
Lea, NC1
Farzaneh, F1
Mufti, GJ1
Blum, W1
Marcucci, G1
Horita, H1
Frankel, AE1
Thorburn, A1

Reviews

1 review available for entinostat and Granulocytic Leukemia

ArticleYear
Targeting epigenetic changes in acute myeloid leukemia.
    Clinical advances in hematology & oncology : H&O, 2005, Volume: 3, Issue:11

    Topics: Acetylation; Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Depsipeptide

2005

Other Studies

3 other studies available for entinostat and Granulocytic Leukemia

ArticleYear
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.
    Oncotarget, 2015, Jan-20, Volume: 6, Issue:2

    Topics: Acute Disease; Aged; Benzamides; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Female; Ge

2015
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.
    Haematologica, 2009, Volume: 94, Issue:5

    Topics: Apoptosis; Azacitidine; Benzamides; Butyrates; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Surviva

2009
Acute-myeloid-leukemia-targeted toxins kill tumor cells by cell-type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death.
    Leukemia, 2008, Volume: 22, Issue:3

    Topics: Acute Disease; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Benzamides; Caspas

2008